New Mexico Register / Volume XXXIII,
Issue 1 / January 11, 2022
This
is an amendment to 16.8.2 NMAC, renumbering Section 43 to Section 49 and adding
new Sections 43 through 48, effective 01/11/2022.
16.8.2.43 CANNABIS
TESTING LABORATORY LICENSE: GENERAL PROVISIONS:
A. Testing
categories: The division may license cannabis testing laboratories to
perform analytical testing of cannabis products in one or more of the following
categories:
(1) visual
inspection;
(2) microbiological;
(3) residual
solvents;
(4) potency
and homogeneity;
(5) heavy
metals;
(6) pesticides;
and
(7) such
other testing categories as the department may identify.
B. License not required for internal testing: A
cannabis establishment may conduct analytical testing using validated methods
for internal quality control purposes without obtaining a cannabis testing
laboratory license but may not offer testing services to another person or
entity.
C. Division application forms: All
applications for licensure authorized pursuant to the Cannabis Regulation Act
shall be made upon current forms prescribed by the division using the online
application portal.
D. Other activities prohibited: No
person with a direct or indirect interest in any cannabis establishment other
than a cannabis research laboratory may hold an interest in a cannabis testing
laboratory.
[16.8.2.43 NMAC – Rp, 16.8.2.43 NMAC, 01/11/2022]
16.8.2.44 APPLICATION
REQUIREMENTS FOR CANNABIS TESTING LABORATORY LICENSE:
A. Contents
of application:
(1) for any
initial or renewal application, contact information for the applicant and the
cannabis establishment, to include:
(a) applicant’s
full legal name;
(b) applicant’s
mailing address;
(c) applicant’s
contact telephone number;
(d) applicant’s
contact email address;
(e) applicant’s
business physical address and mailing address, if different;
(f) applicant’s
business legal name, including a DBA name, if applicable;
(g) applicant’s
business web address, if applicable;
(2) for any
initial application, information about controlling persons, to include:
(a) name and
contact information;
(b) documentation
of legal name change, if applicable;
(c) criminal history
screening documents. as set forth in 16.8.2.9 NMAC and the Cannabis Regulation
Act;
(d) a detailed
description of any criminal convictions, including for each: the date of the
conviction; dates of incarceration, probation, or parole; description of the
offense; and any evidence of rehabilitation, including court documents,
personal or professional references, completion of treatment, employment
records, and other relevant information;
(e) demographic
data pursuant to the Cannabis Regulation Act; and
(f) A
copy of identification issued by a federal or state government, including name,
date of birth, and picture and indicating the person is at least 21 years of
age;
(3) for any renewal application, certifications that the
applicant:
(a) attests
to the following statement: Under penalty of perjury, I hereby declare that the
information contained within and submitted with the application is complete,
true and accurate. I understand that a misrepresentation of fact or violation
of these rules may result in denial of the license application or revocation of
a license issued;
(b) will
adhere to the Cannabis Regulation Act, the Lynn and Erin Compassionate Use Act,
and division rules, including:
(i) testing
requirements;
(ii) transport
requirements;
(iii) security
requirements;
(iv) quality
assurance requirements; and
(v) the
prohibition on any person holding an interest in one or more cannabis testing
laboratories from holding an interest in any other cannabis license other than
a cannabis research laboratory;
(c) will
adhere to applicable federal, state and local laws governing the protection of
public health and the environment, including occupational health and safety,
food safety, fire safety, environmental impacts, natural resource protections,
air quality, solid and hazardous waste management, and wastewater discharge;
(d) has
never been denied a license or had a license suspended or revoked by the
division or any other state cannabis licensing authority or a detailed
description of any administrative orders, civil judgements, denial or
suspension of a cannabis license, revocation of a cannabis license, or
sanctions for unlicensed cannabis activity by any state licensing authority,
against the applicant, controlling person, or a business entity in which the
applicant or controlling person was a controlling person within the three years
immediately preceding the date of the application; and
(e) is
not licensed at the same location under the Liquor Control Act;
(f) has
obtained a current local jurisdiction business license, or will prior to
operation of the cannabis establishment, and the applicant shall adhere to
local zoning ordinance
(4) for
any initial application, and, unless a statement is included that no material
changes exist, for any renewal application:
(a) a
list of categories of testing for which licensure is sought;
(b) legible
and accurate premises diagram containing information required by 16.8.2.46
NMAC, in a portable document format (.pdf), and if requested by the division,
digital photographs;
(c) applicant’s
social and economic equity plan to encourage economic and social diversity in
employment, including race, ethnicity, gender, age, and residential status of
licensee, controlling persons and employees of applicant and whether the
applicant, controlling persons, employees, or premises are located in an
underserved rural community, including tribal, acequia, land grant-merced,
federally designated opportunity zone, or other rural historic communities; and
(5) for
any initial or renewal application, payment of any required fees as set forth
in 16.8.11 NMAC.
B. Initial
demonstration of capability: The division requires the submission of an
initial demonstration of capability (IDC) for every test a cannabis testing
laboratory intends to conduct, except tests for research and development
purposes only. The IDC must identify a limit of quantitation that is equal to
or lower than the action level for the specified test.
(1) An
IDC is required whenever:
(a) an
initial application is submitted, except that an applicant may instead submit
evidence of prior completion of an IDC as a requirement of licensing under the
Lynn and Erin Compassionate Use Act;
(b) the
cannabis testing laboratory proposes to use a new analytical instrument to test
for an analyte; or
(c) the
cannabis testing laboratory proposes material changes to testing methods.
(2) Every
IDC shall include the following elements:
(a) Demonstration
of method calibration: The calibration range shall use at least five
calibration points consisting of five different concentration levels of target
compounds. The calibration range shall include a low calibration point equal
to, or less than, the action level for each targeted compound. The cannabis
testing laboratory shall provide the equation and the type of curve fit used
for the calibration range, and the percent relative standard deviation or the
goodness of fit. The percent relative standard deviation shall be less than
twenty percent, or the goodness of fit (correlation coefficient) shall be 0.995
or better.
(b) Demonstration
of method accuracy and precision: A cannabis testing laboratory shall supply
the quantitation data for five positive control samples analyzed by its testing
method utilizing median or mid-level calibration concentration. The cannabis
testing laboratory shall identify and justify acceptance criteria and shall
calculate and provide the calculated mean (average) result and the standard
deviation. Any standard deviations greater than twenty percent shall be noted
and explained.
(c) Demonstration
of method detection limit: A cannabis testing laboratory shall calculate its
method detection limit using a generally accepted method.
(d) Demonstration
of low system background: A cannabis testing laboratory shall supply the
analytical data of at least three negative control samples that do not contain
any target analytes.
(e) Demonstration
of analyte identification: A cannabis testing laboratory that uses, high
performance liquid chromatography (HPLC) or gas chromatography with flame
ionization detector or photoionization detector (GC-FID or GC-PID/FID)
instrumentation shall supply analytical data where each targeted compound is analyzed
as a single compound giving it its characteristic retention time. A cannabis
testing laboratory that uses gas chromatography–mass spectrometry (GCMS),
liquid chromatography–mass spectrometry (LCMS), or liquid chromatography–tandem
mass spectrometry (LCMSMS) instrumentation shall supply analytical data with
the characteristic mass spectrum of each targeted compound.
C. Continuing demonstration of capability:
A cannabis testing laboratory shall submit a continuing demonstration of
capability (CDC) for each test performed annually as part of the laboratory’s
application for renewal of licensure. A CDC may consist of:
(1) Evidence
that the cannabis testing laboratory has the test within its current scope of accreditation
to the current standards of ISO/IEC 17025, Testing and Calibration
Laboratories;
(2) Evidence
that each analyst performing the test has successfully completed, within the
previous year, relevant proficiency testing administered by a provider
accredited to the standards of ISO/IEC 17043, Conformity Assessment—General
Requirements for Proficiency Testing; or
(3) The
re-performance of the IDC.
D. Verification of information: The
division may verify information contained in each application and accompanying
documentation by:
(1) contacting
the applicant or controlling person by telephone, mail, or electronic mail;
(2) conducting
an on-site visit;
(3) requiring
a face-to-face or virtual meeting and the production of additional documentation;
or
(4) consulting
with state or local governments.
E. Trade secrets: Any applicant
submitting operating procedures and protocols to the division pursuant to the
Lynn and Erin Compassionate Use Act, the Cannabis Regulation Act, or division
rules, may claim such information as a trade secret by clearly identifying such
information as “confidential trade secrets” on the document at the time of
submission. Any claim of confidentiality by an applicant must be based on the
applicant’s good faith belief that the information marked as confidential
constitutes a trade secret as defined in the Uniform Trade Secrets Act,
Sections 57-3A-1 to -7, NMSA 1978. In the event the division receives a request
to inspect such documents, the division will notify the applicant or licensee,
via the current email of record. If the division does not receive an injunction
pursuant to the Uniform Trade Secrets Act within five days of the request to
inspect, the division will make the documents marked confidential available for
inspection as required pursuant to the Inspection of Public Records Act.
[16.8.2.44 NMAC – N, 01/11/2022]
16.8.2.45 SUBMITTAL
OF APPLICATION FOR AMENDED CANNABIS TESTING LABORATORY LICENSE:
A. Application: A cannabis testing laboratory shall submit to the division
an application form for an amended license and obtain approval from the
division, prior to implementing any of the following:
(1) material
or substantial change of the size of the premises;
(2) change
of licensee’s legal or business name;
(3) material
or substantial change in testing methods or equipment;
(4) addition
or elimination of a controlling person;
(5) material
or substantial change to a licensee’s security system; or
(6) material
or substantial modification of the premises.
B. Requirements and processing of application
for amended license: The application for amended license shall:
(1) be
clearly designated as one for an amended license;
(2) supply
any information representing a material change from the most recent application;
and
(3) include
an initial demonstration of capability for any new or materially different
method for performing a required test, including testing for an additional
analyte or testing for an analyte using a different type of instrument.
C. Approval or denial: The division
shall approve or deny an application for amended license within 90 days of
receiving a completed application. Denial of an application for amendment shall
be pursuant to the Uniform Licensing Act.
D. Material or substantial change: Material
or substantial changes requiring approval include:
(1) increase
or decrease in the size of the premises, including the sale of property used
for the cannabis establishment, the purchase of additional property for the use
of the cannabis establishment, or a change in the location of the cannabis
establishment;
(2) testing
for an analyte required in required testing using a different type of
instrument; or
(3) change
to a licensee’s security system, including relocation of security points or
installation of a new security system.
E. Amended license not required:
Other changes to standard operating policies and procedures, unless material or
substantial, may be made without providing notification to the division,
provided that licensees shall maintain at each licensed premises a copy of all
current and prior operating policies and procedures.
[16.8.2.45 NMAC – N, 01/11/2022]
16.8.2.46 PREMISES
DIAGRAM:
A. Detailed diagram required: An
applicant must submit to the division, with the application, a complete and
detailed diagram of the proposed premises. The diagram shall be used by the
division to determine whether the premises meets the requirements of the
Cannabis Regulation Act, the Lynn and Erin Compassionate Use Act, and division
rules. The division shall deny an application if the premises does not qualify
for licensure pursuant to federal, state, or local laws.
B. Contents of diagram: The diagram
shall show:
(1) the
boundaries of the property and the proposed premises to be licensed;
(2) if
applicable, the uses of any portion of the property not included in the
premises;
(3) a
brief statement or description of the principal activity to be conducted in
each area on the premises;
(4) the
dimensions of each area where testing of cannabis products will take place;
(5) the
location and identity of equipment; and
(6) entrances
and exits;
C. Format of diagram: The diagram
shall:
(1) be
drawn to scale;
(2) be
rendered in black and white print; and
(3) contain
no highlighting.
[16.8.2.46 NMAC – N, 01/11/2022]
16.8.2.47 CANNABIS
TESTING LABORATORY POLICIES AND PROCEDURES:
A. Minimum policy and procedure requirements:
A cannabis testing laboratory shall develop, implement, and maintain on the
licensed premises, standard policies and procedures, which shall include the
following:
(1) sample
collection procedures, including:
(a) specifications
for sampling tools and containers;
(b) use
of gloves and other personal protective equipment to prevent contamination of
batches;
(c) access
to complete batches of cannabis products;
(d) determination
of the number of sample increments required, based on batch size; and
(e) random
selection of sample increments;
(2) chain
of custody;
(3) data
recording;
(4) sample
storage and integrity, including sealing of sample containers and, if
applicable, the use of preservatives, inert gas, or other measures;
(5) transportation,
including protection from light, heat, and humidity;
(6) sample
preparation of each matrix for each test;
(7) methodology
for each test, including:
(a) sample
preparation;
(b) reagent,
solution, and reference standard preparation;
(c) instrument
setup, as applicable;
(d) standardization
of volumetric reagent solutions, as applicable;
(e) data
acquisition; and
(f) calculation
of results
(8) data
quality parameters for each test, including:
(a) specificity;
(b) limit
of detection; and
(c) limit
of quantitation;
(9) reporting
of results;
(10) quality
assurance;
(11) employee
policies and procedures, including but not limited to:
(a) adherence
to state and federal laws that do not conflict with the Cannabis Regulation Act
or the Lynn and Erin Compassionate Use Act;
(b) responding
to an emergency, including robbery or a serious accident or incident;
(c) alcohol
and drug-free workplace policies and procedures;
(d) safety
and security procedures;
(e) occupational
health and safety;
(f) crime
prevention techniques; and
(g) if
applicable, confidentiality laws, including the Health Insurance Portability
and Accountability Act of 1996;
(12) equipment
cleaning, maintenance, and inspection standards and schedules;
(13) standards
for labeling, storage, expiration, and re-qualification dates and records
relating to reagents, solutions, and reference standards;
(14) sample
analysis procedures, including but not limited to procedures for the use of
only primary or secondary standards for quantitative analyses;
(15) standards
for data recording, review, storage, and reporting that include, but are not
limited to, standards to ensure:
(a) that
data is recorded in a manner consistent with this rule, and that it is reviewed
to verify that applicable standards of practice, equipment calibration, and
reference standards were applied before reporting;
(b) that
all data, including raw data, documentation, protocols, and reports are
retained in accordance with the requirements of this rule; and
(c) that
reports are the property of the business or individual who provided the sample,
and reports meet the requirements of this rule; and
(16) creation
of chain of custody documentation for each sample.
B. Training program:
(1) Licensee
shall implement a training program, approved by the division, to ensure that
all personnel present at the premises are provided information and training
that, at minimum, covers the following topics within 30 days of the start of
employment:
(a) employee
health and safety;
(b) health
and safety hazards;
(c) hazard
communication;
(d) security
procedures; and
(e) record
keeping/track and trace.
(2) A
cannabis testing laboratory must provide and document training on the following
subjects before permitting any authorized person to independently collect
samples of cannabis products:
(a) an
overview of the process and standard operating procedures of the laboratory;
(b) quality
control procedures, including sterile collection of samples and storage;
(c) chain
of custody, recordkeeping, and tracking requirements;
(d) calibration,
use, and maintenance of measuring devices;
(e) transportation
procedures; and
(f) any
additional information reasonably related to sample collection.
(3) A
cannabis testing laboratory must provide and document training on the following
subjects before an agent or employee independently performs any cannabis
testing process:
(a) an
overview of the process and standard operating procedure(s);
(b) quality
control procedures;
(c) chain
of custody and tracking requirements;
(d) proper
and safe usage of equipment or machinery;
(e) safe
work practices applicable to an employee’s job tasks, including appropriate use
of any necessary safety or sanitary equipment;
(f) cleaning
and maintenance requirements;
(g) emergency
operations, including shutdown; and
(h) any
additional information reasonably related to an employee’s job duties.
C. Training documentation:
(1) Licensee
shall ensure that all personnel receive annual refresher training to cover, at
minimum, the topics listed in this section. The licensee shall maintain a
record which contains at minimum:
(a) a list of all personnel at the premises, including at
minimum, name and job duties of each;
(b) documentation of training topics and dates of training
completion for all personnel;
(c) dates of refresher training completion for all personnel;
and
(d) the signature of each employee verifying receipt and
understanding of each training or refresher training completed.
(2) Licensee may assign responsibility for ensuring compliance
by individual personnel with the requirements of this section to supervisory
personnel.
(3) Licensees
shall maintain documentation of an employee’s training for a period of two
years for current employees and at least six months after the termination of an
employee’s employment.
D. Materials
to be maintained on premises: A cannabis testing laboratory shall maintain
on its premises, and shall promptly present to the department upon request:
(1) all results
of laboratory tests conducted on cannabis or cannabis derived products for a
period of at least two years;
(2) operating
manuals and other documentation for each piece of equipment;
(3) records of required inspection, calibration, and maintenance
for each piece of equipment, including:
(a) the date of the operation;
(b) the person who performed it;
(c) the written procedure used; and
(d) any deviations from the written procedure;
(4) records of non-routine repairs performed on equipment as a
result of failure and malfunction, including:
(a) the nature
of the repair;
(b) how and when the need for the repair was discovered; and
(c) any remedial action taken in response to the repair;
(5) the
certificate of analysis for all reference standards, whether acquired or
internally produced.
(6) current
material safety data sheets for all chemicals used;
(7) documentation of proficiency training.
[16.8.2.47 NMAC – N, 01/11/2022]
16.8.2.48 MINIMUM
STANDARDS FOR THE TESTING OF CANNABIS PRODUCTS:
A. General requirements: Cannabis
testing laboratories shall ensure the following:
(1) testing
is done in premises that are in compliance with state and local laws that do
not conflict with the Cannabis Regulation Act or the Lynn and Erin
Compassionate Use Act; and
(2) weighting
or measuring devices that are used in testing are appropriately documented as
having undergone certified registration and calibration that is in accordance
with requirements of the New Mexico department of agriculture applicable to
commercial transactions.
B. Sample collection: For all
required testing or testing for the purposes of labeling claims, a person
authorized by this rule shall collect the required samples according to the
following guidelines:
(1) Only
the quantity of cannabis product specified in the cannabis testing laboratory’s
operating procedures as necessary for all tests to be performed and to ensure
the proper number of representative samples shall be collected.
(2) The
number of sample increments per batch, as specified in the cannabis testing
laboratory’s operating procedures as necessary for all tests to be performed,
shall be collected.
(a) The
number of sample increments shall not be less than the minimum quantity
specified in Table 2.
(b) Samples
shall be taken randomly throughout the length, width, and depth of the batch.
(c) The
standard sample increment size shall be 0.5 grams, unless specified otherwise
in the cannabis testing laboratory’s operating procedures.
(3) Samples
from the same batch shall be secured in a single use, tamper-evident container that
meets the specifications of the laboratory’s policies and procedures.
(4) Samples
shall be labeled according to the laboratory’s policies and procedures, with,
at minimum:
(a) the
license number of the establishment from which the sample was collected;
(b) the
batch number assigned by the establishment;
(c) the
date the sample was taken;
(d) the
name of the person collecting the sample; and
(e) the
tests to be performed;
(5) If
homogeneity testing is required, each sample increment necessary for
homogeneity testing shall be collected and transported in individual sealed
containers.
Table 1, Minimum quantity of sample increments |
||
Matrix Type
|
Batch Size
|
Minimum Sample Increments |
Dried cannabis |
≤5.0 lbs. |
10 |
>5.0 lbs.; ≤15.0 lbs. |
10 + 5 per pound or fraction thereof above 5 pounds |
|
Other products |
≤2.0 lbs. |
10 |
>2.0 lbs. |
5 per pound |
C. Transportation: All samples shall be transported according to the general requirements
of 16.8.2.13 NMAC and the specifications found in the cannabis testing
laboratory’s policies and procedures.
D. Receipt of test samples: A
cannabis testing laboratory may receive test samples of cannabis products from
any cannabis establishment, adult 21 years of age or older, qualified patient,
or primary caregiver as authorized by this rule.
E. Storage: A cannabis testing
laboratory shall segregate and store cannabis samples in a manner that prevents
contamination or degradations and shall safeguard any cannabis products and
cannabis waste against diversion.
(1) A
cannabis testing laboratory shall provide one or more secure cabinets or vaults
for the storage of cannabis samples, reference standards, and cannabis waste,
and access shall be limited to persons authorized to conduct tests or dispose
of cannabis waste.
(2) Cannabis
samples shall be stored in environmental conditions that minimize physical or
chemical degradation and microbial contamination, including protection from
light, heat, and humidity. Any cannabis product that requires refrigeration
shall be kept at a temperature no greater than 40 degrees Fahrenheit (4 degrees
Celsius) prior to sample preparation.
F. Sample retention and disposal:
(1) Samples
testing positive for a prohibited pesticide must be retained for a minimum of
30 days. All other samples must be retained for a minimum of 15 days. Upon
notification from the division that samples are needed for an investigation by
the division, a law enforcement agency, or another department, the cannabis
testing laboratory shall retain the sample until further directed by the
division.
(2) Any
portion of a cannabis or cannabis-derived test sample that is not destroyed
during analysis shall be:
(a) returned
to the person who provided the sample;
(b) provided
to the division, the state chemist laboratory (department of agriculture), or
state laboratory division for additional testing;
(c) upon
written notification to the department, used to make for internal quality control
purposes; or
(d) destroyed
in accordance with the wastage requirements of this rule.
G. Laboratory premises: A cannabis
testing laboratory shall maintain the premises of the laboratory in a clean and
orderly condition; shall equip the premises with such utensils and equipment as
necessary to conduct the operations of the laboratory; and shall ensure
adequate space for laboratory operations, sample storage, and document storage.
H. Equipment:
(1) Equipment
used for the analysis of test samples shall be adequately inspected, cleaned,
and maintained by laboratory staff, the manufacturer, or other trained persons
according to manufacturer recommendations. Equipment used for the generation or
measurement of data shall be adequately tested and calibrated on an appropriate
schedule, as applicable.
(2) Laboratory
operations shall document procedures setting forth in sufficient detail the
methods and schedules to be used in the routine inspection, cleaning, maintenance,
testing, and calibration of equipment, and shall specify, as appropriate,
remedial action to be taken in the event of failure or malfunction of
equipment. The procedures shall designate the personnel responsible for the
performance of each operation.
(3) Computer
systems used for the analysis of samples, retention of data, sample tracking,
calibration scheduling, management of reference standards, or other critical
laboratory management functions shall ensure that electronic records,
electronic signatures, and handwritten signatures executed to electronic
records are trustworthy, reliable, and generally equivalent to paper records
and handwritten signatures executed on paper.
I. Reagents, solutions, and reference standards:
(1) A
cannabis testing laboratory is authorized to possess reagents, solutions, and
reference standards. Such items shall be:
(a) secured
in accordance with the approved laboratory’s storage policies;
(b) labeled
to indicate identity, date received or prepared, and expiration or
requalification date; and, where applicable, concentration or purity, storage
requirements, and date opened;
(c) stored
under appropriate conditions to minimize degradation or deterioration of the
material; and
(d) used
only within the item’s expiration or requalification date.
(2) Deteriorated
or outdated reagents and solutions shall be properly destroyed.
(3) A
cannabis testing laboratory may:
(a) acquire
commercial reference standards for cannabinoids and other chemicals or
contaminants, for the exclusive purpose of conducting testing for which the
laboratory is approved;
(b) internally
produce reference standards, using standard analytical techniques to document
the purity and concentration of the internally produced reference standards;
(c) obtain
cannabis products from a cannabis establishment for the purpose of producing
reference standards.
J. Recording of analytical data:
(1) A
cannabis testing laboratory shall ensure that all data generated during the
testing of a test sample, except data generated by automated data collection
systems, is recorded directly, promptly, and legibly in ink.
(2) When
automated data collection systems are used, the cannabis testing laboratory
shall log the name of the individual performing the test.
(3) All
data shall be annotated with the date of entry and signed or initialed by the
person recording the data. Any change in entries shall be made so as not to
obscure the original entry, shall indicate the reason for such change, and
shall be dated and signed or initialed at the time of the change.
(4) Any
change in an entry shall:
(a) be
made so as not to obscure the original entry;
(b) indicate
the reason for such change;
(c) be
dated and signed or initialed at the time of the change; and
(d) be
accompanied by a corrective action report to be made available to the division
or the cannabis establishment that submitted the sample upon request for up to
two years after the analysis is completed.
(5) For
each final result reported, a cannabis testing laboratory shall verify that:
(a) any
calculations or other data processing steps were performed correctly;
(b) the
data meet any data quality requirements such as for accuracy, precision,
linearity, etc.;
(c) any
reference standards used were of the appropriate purity and within their
expiration or requalification dates;
(d) any
volumetric solutions were properly standardized before use; and
(e) any
test or measuring equipment used has been properly tested, verified, and
calibrated, and is within its verification or calibration period.
K. Data storage:
(1) A
cannabis testing laboratory shall ensure that all raw data, documentation, protocols,
and certificates of analysis associated with analysis of a test sample are
retained for two years from the date of the completion of analysis.
(2) A
cannabis testing laboratory shall designate an individual as responsible for
records maintenance;
(3) A
cannabis testing laboratory shall maintain the records identified in this
section. Such records must be maintained:
(a) in
a manner that allows retrieval as needed;
(b) under
conditions of storage that minimize deterioration throughout the retention
period; and
(c) in
a manner that prevents unauthorized alteration.
(4) Only
authorized personnel may access the records.
L. Data reporting:
(1) A
certificate of analysis shall contain the following information:
(a) the
date of receipt of the test sample;
(b) the
description of the type or form of the test sample (leaf, flower, powder, oil,
specific edible product, etc.);
(c) the
batch number or code that is associated with the product batch and that is
recorded in the track and trace system;
(d) the identity of the person who
collected the sample;
(e) the
date on which analysis occurred;
(f) the
analytical method used, including at a minimum identification of the type of
analytical equipment used (e.g., GC, HPLC, etc.);
(g) the
analytical results, including units of measure where applicable;
(h) the
identity of the supervisory or management personnel who reviewed and verified
the data and results and ensured that data quality, calibration, and other applicable
requirements were met; and
(i) the
name, address, and contact information of the cannabis testing laboratory that
conducted the test.
(2) The
certificate of analysis shall state that reported analytical results apply only
to the test sample received.
(3) The
certificate of analysis shall contain in minimum 12-point type, all capital
letters, the disclaimer, “UNOFFICIAL TEST RESULTS. NOT VALID FOR TRANSFER OR
SALE” whenever:
(a) The
person submitting the test sample is not a licensed cannabis establishment;
(b) The
test sample was not collected by a person authorized to collect samples for
required testing under this rule; or
(c) The
person submitting the test sample requested that the analysis be performed for
research and development purposes.
[16.8.2.48 NMAC – N, 01/11/2022]
[16.8.2.43]
16.8.2.49 SEVERABILITY: If any part or application of this rule is held to be invalid, the remainder or its application to other situations or persons
shall not be affected. Any section of this rule legally
severed shall not interfere with the remaining protections and duties provided by this rule.
[16.8.2.49
NMAC – Rn, 16.8.2.43 NMAC, 01/11/2022]
History of 16.8.2
NMAC: [RESERVED]